Clinical Laboratory Tests Market

Clinical Laboratory Tests Market by Types (Complete Blood Count, HGB/HCT tests, Basic Metabolic Panel , BUN Creatinine tests, Electrolyte Testing, HbA1c tests, Comprehensive Metabolic Panel, Liver Panel [Hepatitis, Bile Duct Obstruction, Liver Cirrhosis, Liver Cancer, Bone disease, Autoimmune Disorders, and Others], Renal Panel, and Lipid Panel), End-users (Central Laboratories [Complete Blood Count, HGB/HCT, Basic Metabolic Panel, BUN Creatinine Tests, Electrolytes Testing, HbA1c Tests, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, and Lipid Panel], and Primary Clinics[Complete Blood Count, HGB/HCT, Basic Metabolic Panel, BUN Creatinine Tests, Electrolytes Testing, HbA1c Tests, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, and Lipid Panel]), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1006
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 169
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global clinical laboratory tests market size was valued at USD 177 billion in 2019 and is projected to expand at a substantial CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to the growing awareness in health-conscious population and rising presence of chronic diseases.

Clinical Laboratory Tests Market Key Takeaways

Clinical laboratory tests refer to a range of medical tests implemented in a laboratory equipped with all aspects of laboratory instruments and medicine. These tests are done for gathering information about the health of patients, diagnosis of disease, and treating their respective condition. In 2019, International Diabetes Federation published an article and stated that approximately 464 million people were suffering from diabetes and was projected to reach 705 million worldwide by 2045.

Moreover, rising geriatric population and their higher risks of exposing to diseases is a major aspect for the expansion of the clinical laboratory tests. As per the data published by the World Population Prospects in 2019, one in 11 people globally were aged over 65 years and, by 2050, it was projected to become one in six people for people having the aged of 65 years and above. To diagnose age-related diseases, the use for clinical laboratory tests are rising. Other factors such as rising cases of obesity due to lack of proper exercise and consumption of unhealthy food are anticipated to lead the occurrence of several chronic diseases. The demand for clinical laboratory tests is projected to propel significantly due to increasing awareness of regular body profiling between healthcare professionals and patients internationally.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing prevalence of chronic diseases such as cancer and growing number of geriatric population are key drivers boosting the market growth.
  • Rising demand for precise and advanced disease diagnosis solution to improve the treatment is expected to propel the market expansion.
  • Increasing investments in R&D activities for developing innovative diagnosing methods for diseases such as tuberculosis, diabetes, and cardiovascular disorders are driving the growth of the clinical laboratory tests market. 
  • Lack of skilled labors handling the testing and issues related to stringent regulatory policies in different countries are major restraining factors that can hamper the market growth.
  • Technological advancement and rapid development of new techniques for effective handling of tests are projected to offer lucrative opportunities for the market players.

Scope of the Report

The report on the global clinical laboratory tests market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Clinical Laboratory Tests Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types (Complete Blood Count, HGB/HCT tests, Basic Metabolic Panel  , BUN Creatinine tests, Electrolyte Testing, HbA1c tests, Comprehensive Metabolic Panel,  Liver Panel  [Hepatitis, Bile Duct Obstruction, Liver Cirrhosis, Liver Cancer, Bone disease, Autoimmune Disorders, and Others], Renal Panel, and Lipid Panel), End-users (Central Laboratories [Complete Blood Count, HGB/HCT, Basic Metabolic Panel, BUN Creatinine Tests, Electrolytes Testing, HbA1c Tests, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, and Lipid Panel], and Primary Clinics  [Complete Blood Count, HGB/HCT, Basic Metabolic Panel, BUN Creatinine Tests, Electrolytes Testing, HbA1c Tests, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, and Lipid Panel]),

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Abbott, ARUP Laboratories, OPKO Health, Inc., Bioscientia Institut für Medizinische Diagnostik GmbH, Charles River, NeoGenomics Laboratories, Inc., Genoptix, Inc., Healthscope Ltd., Labco, Laboratory Corporation of America Holdings (LabCorp), Fresenius Medical Care; QIAGEN, Quest Diagnostics, Siemens Healthcare Private Limited, Tulip Diagnostics (P) Ltd., Sonic Healthcare, Merck KgaA, and Biosino Bio-technology and Science Inc.


Clinical Laboratory Tests Market Segment Insights

Primary clinics segment is expected to grow at a rapid pace
Based on end-users, the global clinical laboratory tests market is bifurcated into central laboratories and primary clinics. The central laboratories segment is further divided into complete blood count, HGB/HCT, basic metabolic panel, BUN creatinine tests, electrolytes testing, HbA1c tests, comprehensive metabolic panel, liver panel, renal panel, and lipid panel. The central laboratories segment is projected to hold a substantial share of the market in the coming years owing to wide conduction of laboratory tests for various applications such as diseases treatment research and drug discovery. Covance Inc., Eurofins Scientific, Pharmaceutical Product Development and LLC, CIRION BioPharma Research Inc., Phoenix Lab, and Q2 Solutions are some central laboratories present in the market, which fuel the segment growth.

On the other hand, the primary clinics segment is anticipated to register a rapid growth rate during the forecast period as the demand for rapid test results at primary clinical centers are rising significantly due to easy accessibility. Increasing awareness related to laboratory tests in clinics is further expected to drive the market growth during the forecast period. Additionally, introducing advanced technology such as rapid and portable analyzers in the clinics are also estimated to drive the segment growth.

Clinical Laboratory Tests Market By End Users

BMP segment to account for a key share
On the basis of types, the market is divided into complete blood count (CBC), HGB/HCT, basic metabolic panel (BMP), BUN creatinine tests, electrolyte testing, HbA1c tests, comprehensive metabolic panel (CMP), liver panel, renal panel, and lipid panel tests. The liver panel segment is further categorized as hepatitis, bone disease, autoimmune disorders, liver cancer, liver cirrhosis, and bile duct obstruction. The BMP segment held a major market share in 2019 and is projected to account for a key share of the global clinical laboratory tests market in the coming years. Growing occurrence of lifestyle-induced diseases such as obesity and metabolic abnormalities are key drivers for wide adoption of the testing type. However, the lipid panel tests segment is projected to grow at a faster rate during the forecast period owing to rising awareness about the prevalence of cardiovascular disorders and diabetes.

Meanwhile, the liver panel segment is projected to constitute a large market share during the forecast period because of rising prevalence of liver-related disorders such as hepatitis and other diseases. Increasing number of lifestyle disorders as well as increasing consumption of tobacco and alcohol are key drivers for the wide adoption of the testing, thereby, boosting the segment growth.

North America to dominate the market
In terms of regions, the global clinical laboratory tests market is classified as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America dominated the market by representing a key share in 2020 and is anticipated to continue its domination in the market during the forecast period. Rising test volumes and growing penetration of advanced diagnostic techniques are key factors pushing the regional market growth. Moreover, growing incidences of cancer and rising generic population are anticipated to rise the demand for clinical laboratory tests in the region.

On the other hand, the market in Asia Pacific is projected to register a substantial CAGR during the forecast period. Wide implementation of advanced diagnostic technologies and massive supported from governments for the improvement in the healthcare infrastructure by emerging economies such as China and India. Furthermore, positive economic growth, growing scientific research, and unmet medical needs are some untapped opportunities which are primary drivers the regional market growth.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Clinical Laboratory Tests Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Clinical Laboratory Tests Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Clinical Laboratory Tests Market - Supply Chain
  4.5. Global Clinical Laboratory Tests Market Forecast
     4.5.1. Clinical Laboratory Tests Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Clinical Laboratory Tests Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Clinical Laboratory Tests Market Absolute $ Opportunity
5. Global Clinical Laboratory Tests Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Clinical Laboratory Tests Market Size and Volume Forecast by End Users
     5.3.1. Central Laboratories
     5.3.2. Primary Clinics
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Clinical Laboratory Tests Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Clinical Laboratory Tests Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Clinical Laboratory Tests Demand Share Forecast, 2019-2026
7. North America Clinical Laboratory Tests Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Clinical Laboratory Tests Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Clinical Laboratory Tests Market Size and Volume Forecast by End Users
     7.4.1. Central Laboratories
     7.4.2. Primary Clinics
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Clinical Laboratory Tests Demand Share Forecast, 2019-2026
8. Latin America Clinical Laboratory Tests Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Clinical Laboratory Tests Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Clinical Laboratory Tests Market Size and Volume Forecast by End Users
     8.4.1. Central Laboratories
     8.4.2. Primary Clinics
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Clinical Laboratory Tests Demand Share Forecast, 2019-2026
9. Europe Clinical Laboratory Tests Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Clinical Laboratory Tests Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Clinical Laboratory Tests Market Size and Volume Forecast by End Users
     9.4.1. Central Laboratories
     9.4.2. Primary Clinics
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Clinical Laboratory Tests Demand Share Forecast, 2019-2026
10. Asia Pacific Clinical Laboratory Tests Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Clinical Laboratory Tests Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Clinical Laboratory Tests Market Size and Volume Forecast by End Users
     10.4.1. Central Laboratories
     10.4.2. Primary Clinics
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Clinical Laboratory Tests Demand Share Forecast, 2019-2026
11. Middle East & Africa Clinical Laboratory Tests Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Clinical Laboratory Tests Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Clinical Laboratory Tests Market Size and Volume Forecast by End Users
     11.4.1. Central Laboratories
     11.4.2. Primary Clinics
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Clinical Laboratory Tests Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Clinical Laboratory Tests Market: Market Share Analysis
  12.2. Clinical Laboratory Tests Distributors and Customers
  12.3. Clinical Laboratory Tests Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Abbott ARUP Laboratories OPKO Health, Inc. Bioscientia Institut für Medizinische Diagnostik GmbH Charles River NeoGenomics Laboratories, Inc. Genoptix, Inc. Healthscope Ltd.
Segments Covered in the Report
The global clinical laboratory tests market has been segmented on the basis of

Types
  • Complete Blood Count
  • HGB/HCT
  • Basic Metabolic Panel
  • BUN Creatinine Tests
  • Electrolytes Testing
  • HbA1c Tests
  • Comprehensive Metabolic Panel
  • Liver Panel
    • Hepatitis
    • Bile Duct Obstruction
    • Liver Cirrhosis
    • Liver Cancer
    • Bone disease
    • Autoimmune Disorders
    • Others
  • Renal Panel
  • Lipid Panel
End-users
  • Central Laboratories
    • Complete Blood Count
    • HGB/HCT
    • Basic Metabolic Panel
    • BUN Creatinine Tests
    • Electrolytes Testing
    • HbA1c Tests
    • Comprehensive Metabolic Panel
    • Liver Panel
    • Renal Panel
    • Lipid Panel
  • Primary Clinics
    • Complete Blood Count
    • HGB/HCT
    • Basic Metabolic Panel
    • BUN Creatinine Tests
    • Electrolytes Testing
    • HbA1c Tests
    • Comprehensive Metabolic Panel
    • Liver Panel
    • Renal Panel
    • Lipid Panel
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Abbott
  • ARUP Laboratories
  • OPKO Health, Inc.
  • Bioscientia Institut für Medizinische Diagnostik GmbH
  • Charles River
  • NeoGenomics Laboratories, Inc.
  • Genoptix, Inc.
  • Healthscope Ltd.
  • Labco
  • Laboratory Corporation of America Holdings (LabCorp)
  • Fresenius Medical Care
  • QIAGEN
  • Quest Diagnostics
  • Siemens Healthcare Private Limited
  • Tulip Diagnostics (P) Ltd.
  • Sonic Healthcare
  • Merck KgaA
  • Biosino Bio-technology and Science Inc.

Some of the key players competing in the market are Abbott, ARUP Laboratories, OPKO Health, Inc., Bioscientia Institut für Medizinische Diagnostik GmbH, Charles River, NeoGenomics Laboratories, Inc., Genoptix, Inc., Healthscope Ltd., Labco, Laboratory Corporation of America Holdings (LabCorp), Fresenius Medical Care; QIAGEN, Quest Diagnostics, Siemens Healthcare Private Limited, Tulip Diagnostics (P) Ltd., Sonic Healthcare, Merck KgaA, and Biosino Bio-technology and Science Inc.

Major players are mostly focusing on mergers, acquisitions, and strategic partnerships for growing their presence in clinical laboratory tests market. For instance, in 2018, Charles River acquired MPI research which was leading non-clinical contract research organization. The deal was primarily aimed to deliver comprehensive testing services to many medical device and biopharmaceutical companies.

 Clinical Laboratory Tests Market By Key Players

Buy Report